Open access
560
Views
24
CrossRef citations to date
0
Altmetric
Original Research
Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates
Scott A ReismanReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]Correspondence[email protected]
, Sarabjit S GahirReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]
, Chun-Yue I LeeReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]
, Joel W ProkschReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]
, Mitsumasa SakamotoReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]
& Keith W WardReata Pharmaceuticals, Inc., Irving, TX 75063, USA, [email protected]
Pages 1259-1270
|
Published online: 17 Apr 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.